Zhong‐Ying Ma

1.2k total citations
32 papers, 1.0k citations indexed

About

Zhong‐Ying Ma is a scholar working on Oncology, Organic Chemistry and Inorganic Chemistry. According to data from OpenAlex, Zhong‐Ying Ma has authored 32 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 16 papers in Organic Chemistry and 11 papers in Inorganic Chemistry. Recurrent topics in Zhong‐Ying Ma's work include Metal complexes synthesis and properties (23 papers), Ferrocene Chemistry and Applications (11 papers) and Crystal structures of chemical compounds (7 papers). Zhong‐Ying Ma is often cited by papers focused on Metal complexes synthesis and properties (23 papers), Ferrocene Chemistry and Applications (11 papers) and Crystal structures of chemical compounds (7 papers). Zhong‐Ying Ma collaborates with scholars based in China, New Zealand and United States. Zhong‐Ying Ma's co-authors include Jing‐Yuan Xu, Cheng‐Zhi Xie, Xin Qiao, Zhao‐Yan Qiang, Shi‐Ping Yan, Lou Jian-shi, Jia Shao, Xueqing Song, Fei Xue and Yanwen Zhang and has published in prestigious journals such as Journal of Medicinal Chemistry, Biochemical Pharmacology and RSC Advances.

In The Last Decade

Zhong‐Ying Ma

32 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhong‐Ying Ma China 16 735 533 281 252 149 32 1.0k
P. Kalaivani India 25 1.3k 1.8× 1.1k 2.1× 346 1.2× 415 1.6× 268 1.8× 62 1.7k
F. Dallemer France 24 964 1.3× 1.1k 2.0× 278 1.0× 486 1.9× 246 1.7× 49 1.5k
D. Gayathri India 13 293 0.4× 417 0.8× 127 0.5× 142 0.6× 94 0.6× 79 695
Bi‐Qun Zou China 20 613 0.8× 585 1.1× 205 0.7× 146 0.6× 168 1.1× 41 978
Imtiyaz Yousuf India 19 666 0.9× 532 1.0× 254 0.9× 221 0.9× 134 0.9× 32 915
Sandipan Sarkar India 16 303 0.4× 346 0.6× 235 0.8× 183 0.7× 217 1.5× 45 938
S.S. Hindo United States 10 504 0.7× 375 0.7× 225 0.8× 173 0.7× 131 0.9× 10 1.0k
P. Sathyadevi India 14 1.1k 1.5× 813 1.5× 440 1.6× 403 1.6× 172 1.2× 15 1.3k
Mohammed I.M. Wazeer Saudi Arabia 20 312 0.4× 714 1.3× 208 0.7× 145 0.6× 122 0.8× 62 961
Sofia Nikolaou Brazil 17 319 0.4× 255 0.5× 179 0.6× 89 0.4× 281 1.9× 60 734

Countries citing papers authored by Zhong‐Ying Ma

Since Specialization
Citations

This map shows the geographic impact of Zhong‐Ying Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhong‐Ying Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhong‐Ying Ma more than expected).

Fields of papers citing papers by Zhong‐Ying Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhong‐Ying Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhong‐Ying Ma. The network helps show where Zhong‐Ying Ma may publish in the future.

Co-authorship network of co-authors of Zhong‐Ying Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Zhong‐Ying Ma. A scholar is included among the top collaborators of Zhong‐Ying Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhong‐Ying Ma. Zhong‐Ying Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ma, Zhong‐Ying, Xiaojing Ding, Qian Chen, et al.. (2024). Pt(iv) derivatives of cisplatin and oxaliplatin bearing an EMT-related TMEM16A/COX-2-selective dual inhibitor against colorectal cancer cells HCT116. RSC Medicinal Chemistry. 15(9). 3239–3247. 1 indexed citations
2.
Hu, Juanjuan, Zhong‐Ying Ma, Xinrui He, et al.. (2022). Long-acting response of COX-2-mediated metastasis inhibition by oxaliplatin-based CP-L-OHP. New Journal of Chemistry. 46(22). 10637–10643. 1 indexed citations
3.
Liu, Xiaomeng, Zhe Li, Xinrui He, et al.. (2022). Dual-targeting of the aromatase binding domain of heme and androstenedione by Pt(iv) prodrugs: a new treatment for postmenopausal breast cancer. Inorganic Chemistry Frontiers. 9(14). 3470–3483. 10 indexed citations
4.
Ma, Zhong‐Ying, Xueqing Song, Juanjuan Hu, et al.. (2021). Ketoplatin in triple-negative breast cancer cells MDA-MB-231: High efficacy and low toxicity, and positive impact on inflammatory microenvironment. Biochemical Pharmacology. 188. 114523–114523. 10 indexed citations
5.
Ma, Zhong‐Ying, Chunyan Gao, Jin‐Lei Tian, et al.. (2021). Copper based metallonucleases as potential antitumor drugs: Synthesis, Structure, in vitro Cytotoxicity and Apoptosis inducing properties. Journal of Molecular Structure. 1236. 130278–130278. 8 indexed citations
6.
Song, Xueqing, Shuqing Wang, Zhe Li, et al.. (2020). Anticancer Melatplatin Prodrugs: High Effect and Low Toxicity, MT1-ER-Target and Immune Response In Vivo. Journal of Medicinal Chemistry. 63(11). 6096–6106. 34 indexed citations
7.
Wang, Dongbo, Juanjuan Hu, Xueqing Song, et al.. (2019). An iron(iii) complex selectively mediated cancer cell death: crystal structure, DNA targeting andin vitroantitumor activities. Inorganic Chemistry Frontiers. 6(4). 1040–1049. 11 indexed citations
8.
Zhang, Ran, et al.. (2019). Fuplatin: An Efficient and Low-Toxic Dual-Prodrug. Journal of Medicinal Chemistry. 62(9). 4543–4554. 54 indexed citations
9.
Song, Xueqing, et al.. (2019). New NSAID-Pt(IV) prodrugs to suppress metastasis and invasion of tumor cells and enhance anti-tumor effect in vitro and in vivo. European Journal of Medicinal Chemistry. 167. 377–387. 51 indexed citations
10.
Ma, Zhong‐Ying, Dongbo Wang, Xueqing Song, et al.. (2018). Chlorambucil-conjugated platinum(IV) prodrugs to treat triple-negative breast cancer in vitro and in vivo. European Journal of Medicinal Chemistry. 157. 1292–1299. 49 indexed citations
11.
Wang, Yang, Zhong‐Ying Ma, Delong Zhang, et al.. (2018). Highly selective and sensitive turn-on fluorescent sensor for detection of Al3+ based on quinoline-base Schiff base. Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy. 195. 157–164. 94 indexed citations
12.
Li, Ang, Yahong Liu, Zhong‐Ying Ma, et al.. (2015). Association of structural modifications with bioactivity in three new copper(II) complexes of Schiff base ligands derived from 5-chlorosalicylaldehyde and amino acids. Journal of Inorganic Biochemistry. 146. 52–60. 33 indexed citations
13.
Shao, Jia, Zhong‐Ying Ma, Ang Li, et al.. (2014). Thiosemicarbazone Cu(II) and Zn(II) complexes as potential anticancer agents: Syntheses, crystal structure, DNA cleavage, cytotoxicity and apoptosis induction activity. Journal of Inorganic Biochemistry. 136. 13–23. 86 indexed citations
14.
Ma, Zhong‐Ying, et al.. (2012). Synthesis, Structure, and Photoluminescent Property of a Novel 2D Silver(I) Polymer Based on Short Ag-Ag Interactions. Synthesis and Reactivity in Inorganic Metal-Organic and Nano-Metal Chemistry. 42(4). 493–497. 1 indexed citations
15.
Gao, Chunyan, Xin Qiao, Zhong‐Ying Ma, et al.. (2012). Synthesis, characterization, DNA binding and cleavage, BSA interaction and anticancer activity of dinuclear zinc complexes. Dalton Transactions. 41(39). 12220–12220. 94 indexed citations
16.
Qiao, Yi, Jie Peng, Yanyan Jia, et al.. (2011). Pharmacokinetics of metolazone tablet determined by LC-MS/MS in healthy volunteers. Zhongguo xin yao zazhi. 20(24). 2446–2449. 1 indexed citations
17.
Ma, Zhong‐Ying, et al.. (2011). A New Linear Tetranuclear Copper(II) Complex: Synthesis, Structural Characterization, and Magnetic Behavior. Synthesis and Reactivity in Inorganic Metal-Organic and Nano-Metal Chemistry. 41(7). 763–767. 1 indexed citations
18.
Ding, Yi, Wenxing Liu, Chengtao Lu, et al.. (2011). Preclinical pharmacokinetic analysis of felotaxel (SHR110008), a novel derivative of docetaxel, in rats and its protein binding ability in vitro. Biomedicine & Pharmacotherapy. 66(2). 98–102. 7 indexed citations
19.
Qiao, Xin, Zhong‐Ying Ma, Cheng‐Zhi Xie, et al.. (2011). Study on potential antitumor mechanism of a novel Schiff Base copper(II) complex: Synthesis, crystal structure, DNA binding, cytotoxicity and apoptosis induction activity. Journal of Inorganic Biochemistry. 105(5). 728–737. 208 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by P. Kalaivani Breakdown of academic impact, for papers by F. Dallemer Breakdown of academic impact, for papers by D. Gayathri Breakdown of academic impact, for papers by Bi‐Qun Zou Breakdown of academic impact, for papers by Imtiyaz Yousuf Breakdown of academic impact, for papers by Sandipan Sarkar Breakdown of academic impact, for papers by S.S. Hindo Breakdown of academic impact, for papers by P. Sathyadevi Breakdown of academic impact, for papers by Mohammed I.M. Wazeer Breakdown of academic impact, for papers by Sofia Nikolaou
Rankless by CCL
2026